Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 3
2011 1
2012 1
2013 3
2014 5
2015 3
2016 10
2017 11
2018 8
2019 13
2020 14
2021 16
2022 10
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
[Tumor Immunogenicity and Immune Checkpoint Inhibitors].
Nakajima M, Tsunedomi R, Shindo Y, Tokumitsu Y, Matsui H, Watanabe Y, Tomochika S, Yoshida S, Iida M, Suzuki N, Takeda S, Ioka T, Hazama S, Nagano H. Nakajima M, et al. Among authors: iida m. Gan To Kagaku Ryoho. 2022 Sep;49(9):922-927. Gan To Kagaku Ryoho. 2022. PMID: 36156006 Review. Japanese.
Flower in the duodenum (with video).
Hamabe K, Nishikawa J, Goto A, Ogawa R, Hashimoto S, Hoshii Y, Iida M, Nagano H, Takami T. Hamabe K, et al. Among authors: iida m. Gastrointest Endosc. 2022 Aug;96(2):383-384. doi: 10.1016/j.gie.2022.04.058. Epub 2022 Apr 28. Gastrointest Endosc. 2022. PMID: 35489395 No abstract available.
IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer.
Yamamoto T, Tsunedomi R, Nakajima M, Suzuki N, Yoshida S, Tomochika S, Xu M, Nakagami Y, Matsui H, Tokumitsu Y, Shindo Y, Watanabe Y, Iida M, Takeda S, Hazama S, Tanabe T, Ioka T, Hoshii Y, Kiyota A, Takizawa H, Kawakami Y, Ueno T, Nagano H. Yamamoto T, et al. Among authors: iida m. Ann Surg Oncol. 2023 Aug;30(8):5267-5277. doi: 10.1245/s10434-023-13527-y. Epub 2023 May 24. Ann Surg Oncol. 2023. PMID: 37222942
Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial.
Nakajima M, Hazama S, Tokumitsu Y, Shindo Y, Matsui H, Matsukuma S, Nakagami Y, Tamada K, Udaka K, Sakamoto M, Saito A, Kouki Y, Uematsu T, Xu M, Iida M, Tsunedomi R, Suzuki N, Takeda S, Ioka T, Doi S, Nagano H. Nakajima M, et al. Among authors: iida m. Hepatol Res. 2023 Jul;53(7):649-660. doi: 10.1111/hepr.13900. Epub 2023 Mar 30. Hepatol Res. 2023. PMID: 36929310
Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells.
Kimura Y, Tsunedomi R, Yoshimura K, Matsukuma S, Shindo Y, Matsui H, Tokumitsu Y, Yoshida S, Iida M, Suzuki N, Takeda S, Ioka T, Hazama S, Nagano H. Kimura Y, et al. Among authors: iida m. Ann Surg Oncol. 2022 Nov;29(12):7423-7433. doi: 10.1245/s10434-022-12220-w. Epub 2022 Jul 25. Ann Surg Oncol. 2022. PMID: 35876924
Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer.
Chidimatsu H, Tsunedomi R, Nakagami Y, Xu M, Nakajima M, Nakashima-Nakasuga C, Tomochika S, Yoshida S, Suzuki N, Watanabe Y, Matsui H, Shindo Y, Tokumitsu Y, Iida M, Takeda S, Ioka T, Ueno T, Tanabe T, Hoshii Y, Hazama S, Nagano H. Chidimatsu H, et al. Among authors: iida m. Anticancer Res. 2023 Jan;43(1):105-114. doi: 10.21873/anticanres.16139. Anticancer Res. 2023. PMID: 36585204
Identification of a Promiscuous Epitope Peptide Derived From HSP70.
Matsui H, Hazama S, Tamada K, Udaka K, Irie A, Nishimura Y, Miyakawa T, Doi S, Nakajima M, Kanekiyo S, Tokumitsu Y, Shindo Y, Tomochika S, Yoshida S, Iida M, Suzuki N, Takeda S, Yamamoto S, Yoshino S, Ueno T, Nagano H. Matsui H, et al. Among authors: iida m. J Immunother. 2019 Sep;42(7):244-250. doi: 10.1097/CJI.0000000000000274. J Immunother. 2019. PMID: 31398179 Free PMC article.
101 results